CINXE.COM
nitrosamine conference 2024 - Google Search
<!DOCTYPE html PUBLIC "-//WAPFORUM//DTD XHTML Mobile 1.0//EN" "http://www.wapforum.org/DTD/xhtml-mobile10.dtd"><html xmlns="http://www.w3.org/1999/xhtml" lang="en-SG"><head><meta content="application/xhtml+xml; charset=UTF-8" http-equiv="Content-Type"/><meta content="no-cache" name="Cache-Control"/><title>nitrosamine conference 2024 - Google Search</title><style>a{text-decoration:none;color:inherit}a:hover{text-decoration:underline}a img{border:0}body{font-family:arial,sans-serif;padding:8px;margin:0 auto;max-width:700px;min-width:240px;}.FbhRzb{border-left:thin solid #dadce0;border-right:thin solid #dadce0;border-top:thin solid #dadce0;height:40px;overflow:hidden}.n692Zd{margin-bottom:10px}.cvifge{height:40px;border-spacing:0}.QvGUP{height:40px;padding:0 8px 0 8px;vertical-align:top}.O4cRJf{height:40px;width:100%;padding:0;padding-right:16px}.O1ePr{height:40px;padding:0;vertical-align:top}.kgJEQe{height:36px;width:98px;vertical-align:top;margin-top:4px}.lXLRf{vertical-align:top}.MhzMZd{border:0;vertical-align:middle;font-size:14px;height:40px;padding:0;width:100%;padding-left:16px}.xB0fq{height:40px;border:none;font-size:14px;background-color:#1a73e8;color:#fff;padding:0 16px;margin:0;vertical-align:top;cursor:pointer}.xB0fq:focus{border:1px solid #1a73e8}.M7pB2{border:thin solid #dadce0;margin:0 0 3px 0;font-size:13px;font-weight:500;height:40px}.euZec{width:100%;height:40px;text-align:center;border-spacing:0}table.euZec td{padding:0;width:25%}.QIqI7{display:inline-block;padding-top:4px;font-weight:bold;color:#4285f4}.EY24We{border-bottom:2px solid #4285f4}.CsQyDc{display:inline-block;color:#70757a}.TuS8Ad{font-size:14px}.HddGcc{padding:8px;color:#70757a}.dzp8ae{font-weight:bold;color:#3c4043}.rEM8G{color:#70757a}.bookcf{table-layout:fixed;width:100%;border-spacing:0}.InWNIe{text-align:center}.uZgmoc{border:thin solid #dadce0;color:#70757a;font-size:14px;text-align:center;table-layout:fixed;width:100%}.frGj1b{display:block;padding:12px 0 12px 0;width:100%}.BnJWBc{text-align:center;padding:6px 0 13px 0;height:35px}</style></head><body><style>.ezO2md{border:thin solid #dadce0;padding:12px 16px 12px 16px;margin-bottom:10px;font-family:arial,sans-serif}.lIMUZd{font-family:arial,sans-serif}.Dks9wf{width:100%}.KZhhub{border-spacing:0;width:100%}.udTCfd{vertical-align:top;width:100%}.fYyStc{word-break:break-word}.ynsChf{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis}.Fj3V3b{color:#1967d2;font-size:14px;line-height:20px}.FrIlee{color:#202124;font-size:13px;line-height:20px}.F9iS2e{color:#70757a;font-size:13px;line-height:20px}.WMQ2Le{color:#70757a;font-size:12px;line-height:16px}.x3G5ab{color:#202124;font-size:18px;line-height:24px}.fuLhoc{color:#1967d2;font-size:18px;line-height:24px}.epoveb{font-size:32px;line-height:40px;font-weight:400;color:#202124}.dXDvrc{color:#0d652d;font-size:14px;line-height:20px;word-wrap:break-word}.dloBPe{font-weight:bold}.YVIcad{color:#70757a}.JkVVdd{color:#ea4335}.oXZRFd{color:#ea4335}.MQHtg{color:#fbbc04}.pyMRrb{color:#1e8e3e}.EtTZid{color:#1e8e3e}.M3vVJe{color:#1967d2}.qXLe6d{display:block}.NHQNef{font-style:italic}.Cb8Z7c{white-space:pre}a.ZWRArf{text-decoration:none}a .CVA68e:hover{text-decoration:underline}.CSfvHb{padding-bottom:8px}.gNEi4d{table-layout:fixed}.Y0aAmf{text-align:center}.iUhyd{vertical-align:bottom}.CO79Sb{position:relative}.WQbFld{bottom:0;left:0;margin:auto;position:absolute;right:0;top:0;background-image:url(https://www.gstatic.com/search_trustx/visibility_off_icon_p0-7d897bf44bafe5436baa9009e8716337.png);background-repeat:no-repeat;background-position:center;background-size:20px}</style><div class="n692Zd"><div class="BnJWBc"><a class="lXLRf" href="/?start=10&sa=N&sca_esv=0c814c2424608e41&output=search&tbm=nws&ved=0ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChA8CAI"><img class="kgJEQe" src="/images/branding/searchlogo/1x/googlelogo_desk_heirloom_color_150x55dp.gif" alt="Google"/></a></div><div class="FbhRzb"><form action="/search"><input name="sca_esv" value="0c814c2424608e41" type="hidden"/><input name="tbm" value="nws" type="hidden"/><input name="oq" type="hidden"/><input name="aqs" type="hidden"/><table class="cvifge"><tr><td class="O4cRJf"><input class="MhzMZd" value="nitrosamine conference 2024" name="q" type="text"/></td><td class="O1ePr"><input class="xB0fq" value="Search" type="submit"/></td></tr></table></form></div><div class="M7pB2"><table class="euZec"><tbody><tr><td><a class="CsQyDc" href="/search?q=nitrosamine+conference+2024&sca_esv=0c814c2424608e41&source=lnms&sa=X&ved=0ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChD8BQgEKAA">ALL</a></td><td class="EY24We"><span class="QIqI7">NEWS</span></td><td><a class="CsQyDc" href="/search?q=nitrosamine+conference+2024&sca_esv=0c814c2424608e41&tbm=isch&source=lnms&sa=X&ved=0ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChD8BQgGKAI">IMAGES</a></td><td><a class="CsQyDc" href="/search?q=nitrosamine+conference+2024&sca_esv=0c814c2424608e41&tbm=vid&source=lnms&sa=X&ved=0ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChD8BQgHKAM">VIDEOS</a></td></tr></tbody></table></div></div><div><div> <div> <div class="ezO2md"><div><a href="/url?q=https://www.medscape.com/viewarticle/hidradenitis-suppurativa-symptoms-eased-semaglutide-aided-2024a1000hx7&sa=U&ved=2ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChDF9AF6BAgAEAI&usg=AOvVaw35TgyT6Dzlq8bVQl7wx8gL"><div><span class="CVA68e qXLe6d fuLhoc ZWRArf">HS Symptoms Eased by Semaglutide-Aided Weight Loss</span> <span class="qXLe6d dXDvrc"> <span class="fYyStc">Medscape</span> </span> </div><div class="Dks9wf"><table class="KZhhub"><tr><td class="udTCfd"><div> <div> <span class="qXLe6d FrIlee"> <span class="fYyStc">Improvements in the Dermatology Life Quality Index score and hidradenitis suppurativa flares were seen in people who achieved...</span> <br/> <span class="fYyStc YVIcad">1 month ago</span> </span> </div> </div></td><td><div><table class="gNEi4d"><tbody><tr><td style="width:232px"> <div class="CO79Sb"> <img class="iUhyd" alt="" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSjpxuUSWuZur0bG6FfGtK8DAMR7_G806cM3Zy-O2V8Rc2WtJZ18siUC1T6Bw&s" style="width:120px;height:66px"/> </div> </td></tr></tbody></table></div></td></tr></table></div></a></div></div> </div> </div><div> <div> <div class="ezO2md"><div><a href="/url?q=https://www.contractpharma.com/contents/view_breaking-news/2024-02-27/asahi-kasei-minimizes-nitrate-levels-in-pharmaceutical-excipient-ceolus/&sa=U&ved=2ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChDF9AF6BAgIEAI&usg=AOvVaw0LngcPCGCSwotRdSF0PnSo"><div><span class="CVA68e qXLe6d fuLhoc ZWRArf">Asahi Kasei Minimizes Nitrate Levels In Pharmaceutical Excipient Ceolus</span> <span class="qXLe6d dXDvrc"> <span class="fYyStc">Contract Pharma</span> </span> </div><div class="Dks9wf"><table class="KZhhub"><tr><td class="udTCfd"><div> <div> <span class="qXLe6d FrIlee"> <span class="fYyStc">Contributes to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals.</span> <br/> <span class="fYyStc YVIcad">8 months ago</span> </span> </div> </div></td><td><div><table class="gNEi4d"><tbody><tr><td style="width:232px"> <div class="CO79Sb"> <img class="iUhyd" alt="" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcT_N5VzP2XoHfxsGnw0pKZKP4UOVi26bO_b-6Bt-vbJd825qp2sLNFoJc-LAQ&s" style="width:120px;height:66px"/> </div> </td></tr></tbody></table></div></td></tr></table></div></a></div></div> </div> </div><div> <div> <div class="ezO2md"><div><a href="/url?q=https://www.biopharminternational.com/view/the-recent-discoveries-of-nitrosamine-impurities-pda-fda-joint-regulatory-conference-2023-&sa=U&ved=2ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChDF9AF6BAgFEAI&usg=AOvVaw1gNbAl9ff50ACfjilj7Abr"><div><span class="CVA68e qXLe6d fuLhoc ZWRArf">The Recent Discoveries of Nitrosamine Impurities (PDA/FDA Joint Regulatory Conference 2023)</span> <span class="qXLe6d dXDvrc"> <span class="fYyStc">BioPharm International</span> </span> </div><div class="Dks9wf"><table class="KZhhub"><tr><td class="udTCfd"><div> <div> <span class="qXLe6d FrIlee"> <span class="fYyStc">Sander Van Gessel, MEng, Business Unit Director, DFE Pharma, discusses the recent findings of nitrosamine impurities in human drugs as a...</span> <br/> <span class="fYyStc YVIcad">13 months ago</span> </span> </div> </div></td><td><div><table class="gNEi4d"><tbody><tr><td style="width:232px"> <div class="CO79Sb"> <img class="iUhyd" alt="" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRr4Oj6c_UcFDZHhLTLO6LqDNlY9IrUHUwWGbNYXlyUSV68cjEXy6zJcWe6MA&s" style="width:120px;height:66px"/> </div> </td></tr></tbody></table></div></td></tr></table></div></a></div></div> </div> </div><div> <div> <div class="ezO2md"><div><a href="/url?q=https://www.contractpharma.com/contents/view_breaking-news/2024-10-14/aptar-csps-n-sorb-accepted-to-fdas-emerging-tech-program/&sa=U&ved=2ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChDF9AF6BAgJEAI&usg=AOvVaw39CZItMrRgkfujA7noTzCv"><div><span class="CVA68e qXLe6d fuLhoc ZWRArf">Aptar CSP鈥檚 N-Sorb Accepted To FDA鈥檚 Emerging Tech Program</span> <span class="qXLe6d dXDvrc"> <span class="fYyStc">Contract Pharma</span> </span> </div><div class="Dks9wf"><table class="KZhhub"><tr><td class="udTCfd"><div> <div> <span class="qXLe6d FrIlee"> <span class="fYyStc">Leverages Aptar's 3-Phase Activ-Polymer platform technology to help address concerns related to N-nitrosamine impurities.</span> <br/> <span class="fYyStc YVIcad">1 month ago</span> </span> </div> </div></td><td><div><table class="gNEi4d"><tbody><tr><td style="width:232px"> <div class="CO79Sb"> <img class="iUhyd" alt="" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRctPVfa3wQZnKUKyeJ-SZH9eyOkggqxHzymzo5W02o_Qgum9F_hczArK7x_A&s" style="width:120px;height:66px"/> </div> </td></tr></tbody></table></div></td></tr></table></div></a></div></div> </div> </div><div> <div> <div class="ezO2md"><div><a href="/url?q=https://www.smfederation.org.sg/news/closed-door-dialogue-sessions-health-sciences-authority-hsa&sa=U&ved=2ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChDF9AF6BAgGEAI&usg=AOvVaw0d7iKFpbrRgXy02-RKj1D6"><div><span class="CVA68e qXLe6d fuLhoc ZWRArf">Closed-Door Dialogue Sessions with the Health Sciences Authority (HSA)</span> <span class="qXLe6d dXDvrc"> <span class="fYyStc">Singapore Manufacturing Federation</span> </span> </div><div class="Dks9wf"><table class="KZhhub"><tr><td class="udTCfd"><div> <div> <span class="qXLe6d FrIlee"> <span class="fYyStc">During both dialogue sessions, topics such as regulatory initiatives and collaborations, upcoming implementations and HSA initiatives were discussed.</span> <br/> <span class="fYyStc YVIcad">33 months ago</span> </span> </div> </div></td><td><div><table class="gNEi4d"><tbody><tr><td style="width:232px"> <div class="CO79Sb"> <img class="iUhyd" alt="" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcS-nT42uCY0JoicsbhFU-b5TtYXYIBhhsL971vrUelkXUytV0SolK2AFLadBw&s" style="width:120px;height:66px"/> </div> </td></tr></tbody></table></div></td></tr></table></div></a></div></div> </div> </div><div> <div> <div class="ezO2md"><div><a href="/url?q=https://www.fda.gov/drugs/news-events-human-drugs/generic-drugs-forum-gdf-2024-regulatory-considerations-enhance-generic-drug-access-04102024&sa=U&ved=2ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChDF9AF6BAgHEAI&usg=AOvVaw1gYvxC3117oopA7P0rghvk"><div><span class="CVA68e qXLe6d fuLhoc ZWRArf">Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug Access</span> <span class="qXLe6d dXDvrc"> <span class="fYyStc">Food and Drug Administration (.gov)</span> </span> </div><div class="Dks9wf"><table class="KZhhub"><tr><td class="udTCfd"><div> <div> <span class="qXLe6d FrIlee"> <span class="fYyStc">The Generic Drugs Forum is an annual, two-day event that offers attendees the opportunity to hear from FDA subject matter experts from every part of the pre-...</span> <br/> <span class="fYyStc YVIcad">9 months ago</span> </span> </div> </div></td><td><div><table class="gNEi4d"><tbody><tr><td style="width:232px"> <div class="CO79Sb"> <img class="iUhyd" alt="" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTmE2d76N5c3mUWfHf5_yiT86tBs0lbcBAAkQ2LSfr56-ceOpl80cxhk24UwQ&s" style="width:120px;height:66px"/> </div> </td></tr></tbody></table></div></td></tr></table></div></a></div></div> </div> </div><div> <div> <div class="ezO2md"><div><a href="/url?q=https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/nitrosamine-impurities/medications-guidance.html&sa=U&ved=2ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChDF9AF6BAgDEAI&usg=AOvVaw2HT2J3p1Yc0zEN4chBM6nm"><div><span class="CVA68e qXLe6d fuLhoc ZWRArf">Nitrosamine impurities in medications: Guidance</span> <span class="qXLe6d dXDvrc"> <span class="fYyStc">Canada.ca</span> </span> </div><div class="Dks9wf"><table class="KZhhub"><tr><td class="udTCfd"><div> <div> <span class="qXLe6d FrIlee"> <span class="fYyStc">This guidance represents Health Canada's current thinking and recommendations on issues related to N-nitrosamine impurities (nitrosamine...</span> <br/> <span class="fYyStc YVIcad">31 months ago</span> </span> </div> </div></td><td><div><table class="gNEi4d"><tbody><tr><td style="width:171px"> <div class="CO79Sb"> <img class="iUhyd" alt="" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRCa-X6osd2vfxVgPWyF9kO0HRl2lrxxgDd-TwMNBBiyv83FXpmYPmdPzB0Wr4&s" style="width:120px;height:89px"/> </div> </td></tr></tbody></table></div></td></tr></table></div></a></div></div> </div> </div><div> <div> <div class="ezO2md"><div><a href="/url?q=https://www.contractpharma.com/csd/profile/bachem-116476/view_how-to-assess-and-reduce-nitrosamine-contamination-risks-in-peptide-apis/&sa=U&ved=2ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChDF9AF6BAgEEAI&usg=AOvVaw2WpI2pMNctd22qzTYWXVhM"><div><span class="CVA68e qXLe6d fuLhoc ZWRArf">How To Assess And Reduce Nitrosamine Contamination Risks In Peptide APIs</span> <span class="qXLe6d dXDvrc"> <span class="fYyStc">Contract Pharma</span> </span> </div><div class="Dks9wf"><table class="KZhhub"><tr><td class="udTCfd"><div> <div> <span class="qXLe6d FrIlee"> <span class="fYyStc">Recent years have seen drug recalls based on nitrosamine drug substance related impurities (NDSRIs), with medical agencies advising API...</span> <br/> <span class="fYyStc YVIcad">3 months ago</span> </span> </div> </div></td><td><div><table class="gNEi4d"><tbody><tr><td style="width:232px"> <div class="CO79Sb"> <img class="iUhyd" alt="" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSSUX8SU6ZR6Ll9q-VTqXgUs-7J1io4Yd3geJGsLwPIAkDCg5LSUumrBVgZHg&s" style="width:120px;height:66px"/> </div> </td></tr></tbody></table></div></td></tr></table></div></a></div></div> </div> </div><div> <div> <div class="ezO2md"><div><a href="/url?q=https://www.labmate-online.com/news/mass-spectrometry-and-spectroscopy/41/breaking-news/what-are-the-safe-limits-for-nitrosamines/59537&sa=U&ved=2ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChDF9AF6BAgCEAI&usg=AOvVaw2WV6u0BVZsQyd59WFCSXZ8"><div><span class="CVA68e qXLe6d fuLhoc ZWRArf">What Are the Safe Limits for Nitrosamines?</span> <span class="qXLe6d dXDvrc"> <span class="fYyStc">Labmate Online</span> </span> </div><div class="Dks9wf"><table class="KZhhub"><tr><td class="udTCfd"><div> <div> <span class="qXLe6d FrIlee"> <span class="fYyStc">As potentially carcinogenic compounds, nitrosamine concentrations are heavily regulated in consumer products. Click to read more...</span> <br/> <span class="fYyStc YVIcad">22 months ago</span> </span> </div> </div></td><td><div><table class="gNEi4d"><tbody><tr><td style="width:232px"> <div class="CO79Sb"> <img class="iUhyd" alt="" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcS8QXC4M18Q6MPu7rZEd6wYN7KPjZdQgJ0fSjk-T_fkaZFyDpDsEyTGw-NklA&s" style="width:120px;height:66px"/> </div> </td></tr></tbody></table></div></td></tr></table></div></a></div></div> </div> </div><div> <div> <div class="ezO2md"><div><a href="/url?q=https://www.pharmtech.com/view/nitrosamines-elemental-impurities-extractables-and-leachables-a-new-normal-for-the-pharma-industry&sa=U&ved=2ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChDF9AF6BAgBEAI&usg=AOvVaw0EDCdW8W_JxgrPC_GntHUr"><div><span class="CVA68e qXLe6d fuLhoc ZWRArf">Nitrosamines, Elemental Impurities, Extractables and Leachables: A New Normal for the Pharma Industry</span> <span class="qXLe6d dXDvrc"> <span class="fYyStc">PharmTech</span> </span> </div><div class="Dks9wf"><table class="KZhhub"><tr><td class="udTCfd"><div> <div> <span class="qXLe6d FrIlee"> <span class="fYyStc">In this webinar, experts will discuss the current regulatory expectations for extractables and leachables (E&L), elemental impurities, and nitrosamines testing.</span> <br/> <span class="fYyStc YVIcad">13 months ago</span> </span> </div> </div></td><td><div><table class="gNEi4d"><tbody><tr><td style="width:232px"> <div class="CO79Sb"> <img class="iUhyd" alt="" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQ7nEYKzIJpk427F01QxnvV6VtBzsRkgsoAeOu88Lf6StjNfcAnywK8P33vrA&s" style="width:120px;height:66px"/> </div> </td></tr></tbody></table></div></td></tr></table></div></a></div></div> </div> </div></div><table class="uZgmoc"><tbody><tr><td></td><td><a class="frGj1b" href="/search?q=nitrosamine+conference+2024&sca_esv=0c814c2424608e41&tbm=nws&ei=G69GZ5a6HMqVjuMP8rfIwQY&start=0&sa=N"><</a></td><td><span class="frGj1b">Page 2</span></td><td><a class="frGj1b" href="/search?q=nitrosamine+conference+2024&sca_esv=0c814c2424608e41&tbm=nws&ei=G69GZ5a6HMqVjuMP8rfIwQY&start=20&sa=N"><span>></span></a></td><td></td></tr></tbody></table><br/><div class="TuS8Ad" data-ved="0ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChCnKghF"><style>.VYM29{font-weight:bold}</style><div class="HddGcc" align="center"><span class="VYM29">Singapore</span><span> - </span><span>From your IP address</span><span> - </span><a href="/url?q=https://support.google.com/websearch%3Fp%3Dws_settings_location%26hl%3Den-SG&opi=89978449&sa=U&ved=0ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChC3LghG&usg=AOvVaw3nE7p8y6ksLWIttEKYkVih">Learn more</a></div><div align="center"><a class="rEM8G" href="/url?q=https://accounts.google.com/ServiceLogin%3Fcontinue%3Dhttps://www.google.com/search%253Fq%253Dnitrosamine%252Bconference%252B2024%2526sca_esv%253D0c814c2424608e41%2526tbm%253Dnws%2526ei%253D-4xGZ9jACamUg8UPi9_QuA8%2526start%253D10%2526sa%253DN%26hl%3Den&opi=89978449&sa=U&ved=0ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChDGzwIIRw&usg=AOvVaw3MOSQ6-o-8aBgRTAxjfcR-">Sign in</a></div><div><table class="bookcf"><tbody class="InWNIe"><tr><td><a class="rEM8G" href="https://www.google.com/preferences?hl=en&sa=X&ved=0ahUKEwjWs7Pr5PuJAxXKimMGHfIbMmg4ChC_lgQISA">Settings</a></td><td><a class="rEM8G" href="https://www.google.com/intl/en_sg/policies/privacy/">Privacy</a></td><td><a class="rEM8G" href="https://www.google.com/intl/en_sg/policies/terms/">Terms</a></td></tr></tbody></table></div></div><div> </div></body></html>